Abstract
Tendon injuries are very common and result in significant impairments in mobility and quality of life. During healing, tendons produce a scar at the injury site, characterized by abundant and disorganized extracellular matrix and by permanent deficits in mechanical integrity compared to healthy tendon. Although a significant amount of work has been done to understand the healing process of tendons and to develop potential therapeutics for tendon regeneration, there is still a significant gap in terms of assessing the direct effects of therapeutics on the functional and material quality specifically of the scar tissue, and thus, on the overall tendon healing process. In this study, we focused on characterizing the mechanical properties of only the scar tissue in flexor digitorum longus (FDL) tendons during the proliferative and early remodeling healing phases and comparing these properties with the mechanical properties of the composite healing tissue. Our method was sensitive enough to identify significant differences in structural and material properties between the scar and tendon-scar composite tissues. To account for possible inaccuracies due to the small aspect ratio of scar tissue, we also applied inverse finite element analysis (iFEA) to compute mechanical properties based on simulated tests with accurate specimen geometries and boundary conditions. We found that the scar tissue linear tangent moduli calculated from iFEA were not significantly different from those calculated experimentally at all healing timepoints, validating our experimental findings, and suggesting the assumptions in our experimental calculations were accurate. Taken together, this study first demonstrates that due to the presence of uninjured stubs, testing composite healing tendons without isolating the scar tissue overestimates the material properties of the scar itself. Second, our scar isolation method promises to enable more direct assessment of how different treatment regimens (e.g., cellular ablation, biomechanical and/or biochemical stimuli, tissue engineered scaffolds) affect scar tissue function and material quality in multiple different types of tendons.
Keywords: Biomechanics, tendon injury, regenerative healing, scar tissue, function
Introduction
Tendons are highly organized fibrous musculoskeletal tissues that function by transmitting muscle-generated forces to the bones and enabling skeletal movement. Tendon injuries are very common and account for more than 30% of all musculoskeletal consultations1,2. In the US alone, there are more than 300,000 tendon and ligament repair surgeries performed annually3. After injury, tendons demonstrate a scar-mediated reparative response rather than a regenerative healing phenotype and produce fibrotic tissue around the healing region that is characterized by abundant and disorganized extracellular matrix (ECM). The persistent fibrotic tissue is mechanically inferior compared to the native tendon, and results in permanent impairment of full tendon function2,4–7 due to a combination of insufficient restoration of mechanical properties, which significantly increases the risk of re-injury8, and the formation of peritendinous adhesions or connections between the tendon and surrounding tissues which impairs tendon movement9,10.
A tremendous amount of work has focused on improving our understanding of the biology of tendon homeostasis and healing, and on identifying potential regenerative approaches to improve tendon healing. For example, many studies have focused on the role of different tendon ECM components (e.g., Collagen V, VI, Decorin, Biglycan) in the maintenance of tendon homeostasis and during healing11–16. Other studies have focused on improving tendon healing by utilizing different biochemical molecules or signaling pathways such as the NF-kΒ pathway, TGF-β, aspirin, and Tenomodulin9,17–24. Finally, an increasing number of studies have tried to understand and exploit the functions of different tendon and non-tendon cell populations (resident tendon cells, adipose-derived stem cells, induced pluripotent stem cells, immune cells) to achieve tendon regeneration during healing20,21,25–29. Unfortunately, although the above studies have offered a significant amount of multidisciplinary knowledge and may identify future potential therapeutic approaches, there is still no consensus therapy in clinical use. Therefore, pre-clinical animal models continue to have great importance with respect to better defining the molecular and cellular mediators of the healing process, and in understanding how different therapeutics modulate healing, with an important emphasis on understanding how specific treatment modalities alter the material quality of tendon scars.
Uniaxial tensile testing is the “gold” standard method to assess the physiologically relevant function and material quality of healing tendons. Traditionally, at the post-injury timepoint of interest the tendon tissue is dissected, cleaned by removing any extra non-tendon tissues, gripped by the 2 tendon edges, placed in some type of buffer e.g., 1X Phosphate Buffer Solution (PBS) to keep the tendon hydrated, and is uniaxially tensile stretched in a displacement-controlled manner until failure. Typically, the tendon gauge length involves a composite tissue of both un-injured tendon adjacent to the injury/repair site and the healing scar tissue region where the injury occurred17,30–37. However, up to this point, the potential relative mechanical contribution of only the scar tissue/healing region during tendon healing is unknown. Moreover, given that the scar tissue represents the mechanically weakest region in the healing tendon38,39, a more precise characterization of the scar tissue material properties will likely provide important insights in the efficacy of a treatment regimen in terms of improved tendon function and material quality.
In the present study, our objective was to describe a method allowing for the determination of the true material properties of the scar tissue at different early healing timepoints in a sensitive and robust way. Next, to validate the assumptions of our experimental calculations, we more directly computed scar tissue material properties using inverse finite element modeling (iFEM) with accurate specimen geometries and boundary conditions. We hypothesized that the scar tissue of FDL tendons will exhibit smaller tangent modulus values compared to the tendon-scar composite tissue at multiple healing timepoints.
Materials and Methods
Mice
All studies were approved by the University Committee on Animal Resources. Wildtype mice on a C57Bl/6J background were used for this study. All mouse studies were performed with 10–12-week-old male and female mice. All mouse work (surgeries, harvests) was performed in the morning. Mice were kept on a 12-hour light/dark cycle.
Flexor Tendon Repair
Complete transection and repair of the murine flexor digitorum longus (FDL) tendon was performed as previously described40. Briefly, mice were injected prior to surgery with 15–20μg of sustained-release buprenorphine analgesic. Mice were anesthetized with Ketamine (100mg/kg) and Xylazine (4mg/kg). Following sterilization of the surgery region, the flexor tendon was transected at the myotendinous junction (MTJ) to reduce early-stage strain-induced rupture of the repair site and the skin was closed with a 5–0 suture. A small incision was made on the posterior surface of the hindpaw, the FDL tendon was located and completely transected using micro spring-scissors. The tendon was repaired using 8–0 suture and the skin was closed with a 5–0 suture. Following surgery, animals resumed prior cage activity, food intake, and water consumption.
Scar and tendon-scar composite tissue dissection and preparation for mechanical testing
The FDL tendon was carefully separated from the calf muscle under a dissecting microscope. The tarsal tunnel was then cut and the FDL tendon was slowly released from the tarsal tunnel and isolated until just proximal to the healing region. Next, the distal FDL was cut and separated at the bifurcation of the digits and isolated proximally until just distal to the healing region. Finally, the healing region was carefully isolated, and the intact healing FDL tendon was placed in a new petri dish. Under the dissecting microscope, any additional connective tissues were removed, and the tendon-scar composite FDL tendon was prepared for testing. Scar tissue was evident in all dissected FDL tendons.
To isolate only the scar tissue and grip it for uniaxial tensile testing, two pieces of sandpaper were placed on each end of the scar tissue and glued together using cyanoacrylate (Superglue, LOCTIE) to grip it in such a way where the gauge length of the gripped tissue included only the scar and not any ‘native’ tendon proximal or distal to the repair site. For gripping of the tendon-scar composite tissue, approximately 1.3–1.5 mm of native tendon was included proximal and distal to the repair site. We directly excluded any specimens where glue was visible on the scar or composite tissue itself. All the steps above were performed with the tissue being constantly submerged in PBS to avoid any potential tissue drying.
Quantification of scar and tendon-scar composite tissue dimensions
Each gripped FDL tendon sample was transferred into a semi-customized uniaxial microtester (eXpert 4000 MicroTester, ADMET, Inc., Norwood MA). The microtester, along with the sample, was transferred to an inverted microscope (Olympus BX51, Olympus) to visualize the FDL tendon and quantify the gauge length, the width, and the thickness. The gauge length of each sample was set as the end-to-end distance between the sandpapers. The cross-section of the tendon was assumed to be an ellipse, where the width of the tissue represents the major axis, while the thickness of the tissue represents the minor axis of the ellipse, as previously described41,42. To quantify the width and thickness of the FDL scar and the tendon-scar composite groups, three sub-equal measurements for each parameter were taken across the scar tissue (proximal, central, and distal scar) and across the tendon-scar composite tissue (proximal tendon, scar, and distal tendon), and the average value of the width and thickness were set as the representative values, respectively.
Uniaxial tensile testing
A uniaxial displacement-controlled stretching of 1% strain per second until failure was applied for both the scar tissue and the tendon-scar composite tissue by utilizing the uniaxial microtester after quantifying the dimensions of each tested tendon (gauge length, CSA). Load and grip-grip displacement data were recorded, and the failure mode was tracked for each mechanically tested sample. All samples from both groups (scar and tendon-scar composite tissues) during the proliferative and early remodeling healing phases (D14 and D21 post-surgery), failed at the midsubstance after the uniaxial tensile stretch. The tensile stress was taken to equal the recorded load divided by the initial CSA, while the tensile strain was taken to equal the recorded grip-grip displacement divided by the gauge length. The load-displacement and stress-strain data were plotted and analyzed to determine structural (stiffness, peak load) and material (modulus, peak stress) properties. The slope of the linear region from the load displacement graph during the tensile testing was determined to be the stiffness of the tested sample 43. The maximum load recorded from the load-displacement graph during the tensile testing was determined to be the peak load parameter of the tested sample. The slope of the linear region from the stress-strain graph during the tensile testing was taken to equal the tangent modulus parameter of each tested tendon. Note that this calculation assumes that stress and strain are uniform within each specimen. Finally, the maximum stress value recorded from the stress-strain graph during the tensile testing was determined to be the peak stress (or strength) of the tested tendon tissue. The structural properties provide information about the mechanical integrity of the tendon which depends on the tendon cross-sectional area. The material properties provide information about the intrinsic material quality of the tissue independently of the cross-sectional area, and thus can be used as a metric outcome of tendon function.
Finite Element Model Construction and iFE analysis for linear tangent modulus quantification
Because the tested specimens had small aspect ratios (gauge length/width ~ 1.1 for at the proliferative and 1.7 at the early remodeling phase), stress and strain distributions induced during tensile testing were presumably nonuniform (according to Saint-Venant’s principle). Therefore, it was necessary to test the validity of our assumption that modulus can be computed from the slope of the overall tissue stress versus tissue strain curve in the linear region. To this end, 3D finite element models of each experimentally tested FDL scar tissue at both D14 and D21 post-surgery were created (Figure 4. B, C). First, elliptic cylinders with accurate dimensions (gauge length, width, and thickness) matching each tested specimen were generated in OnShape, Next, each scar geometry was imported into FEBio and meshed. The number of elements in each model was 14,084 and the number of nodes was 3,205. To accurately reflect the effects of specimen gripping, fixed boundary conditions (in all directions) were applied at one end of the scar, while the moving end was fixed perpendicular to the direction of stretching (i.e., perpendicular to the long axis of the elliptic cylinder).
Each experimental mechanical test was simulated in FEBio starting from the beginning of the linear region. To identify the exact start and end point of the linear region, we applied a linear regression model to our experimental data, quantified the corresponding R2 value, and only groups of points with values of R2 ≥ 0.995 were accepted as part of the linear region (Figure 4. A). The recorded displacement (relative to the beginning of the linear region) was applied to moving end of the elliptic cylinder in the finite element model.
The scar tissue was modeled as a neo-Hookean material. Because we restricted our simulations to the linear region of the stress-strain curve, we chose a constitutive relationship model that has linear behavior for small strains. Because scar tissue is poorly aligned (Fig. 1A, B), we chose an isotropic model.
To calculate the tangent modulus from the simulations, we utilized an iterative optimization approach (inverse finite element analysis, or iFEA) implemented in FEBio. Specifically, the modulus of the simulated scar was assumed as an initial arbitrary number, the above stretching simulation was performed, and the simulated reaction force at the fixed boundary was quantified. The correct/true value of the modulus for each simulation was identified when the simulated reaction force from FEBio matched (difference between FEBio-simulated and experimental reaction force <1%) the experimental force at the end of the linear region. Next, we recorded the coordinates (force, displacement) in both the start and end of each linear region which represented the specific load and displacement each scar tissue could withstand before entering the plastic deformation.
Histological evaluation of tendon healing
Hindpaws containing the repaired FDL tendon were harvested at D14 and D21 post-repair (n=4 per time-point) as previously described29,44. Briefly, the hindpaw was disarticulated at the distal tibia, skin on the top of the foot was removed, and samples were fixed in 10% neutral buffered formalin for 72h with the ankle fixed at ~90°. The tissue was then decalcified for 14 days and processed for paraffin histology. Five-micron serial sections were cut through sagittal plane of the foot and stained with Alcian Blue/ Hematoxylin/ Orange G (ABHOG). Stained slides were digitally imaged using a VS120 Virtual Slide Microscope (Olympus).
Statistical analysis
Quantitative data was analyzed via GraphPad Prism and is presented as mean ± standard deviation (SD). A student’s t-test was used to analyze the gauge length and mechanical properties data between the scar and the tendon-scar composite tissue., as well as between the experimentally calculated and FEBio-based tangent moduli. A one-way ANOVA followed by Tukey’s post-hoc analysis was used to analyze the width and thickness data between the three different regions in the scar and the tendon-scar composite tissue. p values ≤ 0.05 were considered significant. * indicates p<0.05, ** indicates p<0.01, *** indicates p<0.001, **** indicates p<0.0001.
Results
Scar tissue is shorter and more homogeneous in width and thickness compared to the composite tissue.
Morphological staining of the healing tendons was consistent with our previous characterization of the FDL healing process19–21,40,45, and demonstrated the formation of bridging scar tissue between the ends of the native tendon at the repair site on the proliferative and early remodeling healing phase (D14 and D21) (Figure 1A &B), suggesting potential partial restoration of mechanical intergrity. Morphologically, the thickness of the repair site is decreased from D14 to D21 and ECM alignment is enhanced, consistent with early tissue remodeling, and increased integration of the healing tissue-native tendon is observed. Consistent with our histology, we dissected the healing tendon scar tissue along with extra proximal and distal tendon. Dissected tendons were gripped using sandpaper on both ends, their dimensions were quantified, and tensile testing was performed.
To quantify the dimensions of the scar and the tendon-scar composite groups, as described above, three sub-equal measurements were taken across the tissues and the average value of the width and thickness were set as their representative values, respectively (Figure 2A &B). At D14 post-surgery, the scar tissue had a 63% shorter gauge length compared to the tendon-scar composite tissue (p<0.0001) (Figure 2C). The scar tissue had a relatively homogeneous width (proximal scar =1.88 ± 0.049mm; central scar =1.9 ±0.046mm; distal scar =1.88 ± 0.05mm) and thickness (proximal scar =1.51 ± 0.139mm; central scar =1.54 ± 0.141mm; distal scar =1.52 ± 0.141mm) (Figure 2D &E). In contrast, the tendon-scar composite tissue had a more heterogeneous width with proximal tendon (1.03 ± 0.097mm) being significantly lower compared to scar tissue (1.7 ± 0.029mm, p<0.0001) and distal tendon (1.53 ± 0.042mm, p<0.001), while scar tissue was significantly higher than distal tendon (p<0.01) (Figure 2F). Similarly, the thickness was also heterogeneous, with proximal tendon (0.95 ± 0.088mm) being significantly lower compared to scar tissue (1.52 ± 0.029mm, p<0.0001) and distal tendon (1.26 ± 0.044mm, p<0.001), while scar tissue was significantly higher than distal tendon (p<0.01) (Figure 2G).
At 21 days post-surgery, the scar tisue was approximately 49% shorter than the tendon-scar composite tissue (p<0.00001) (Figure 2H). Both the width (proximal scar =1.6 ±0.043mm; central scar =1.62 ± 0.034mm; distal scar =1.6 ± 0.038mm) and thickness (proximal scar =1.39 ± 0.02mm; central scar =1.42 ± 0.0149mm; distal scar =1.39 ± 0.026mm) (Figure 2I &J) of the scar tissue were homogeneous, consistent with 14 days post-surgery. In contrast, the tendon-scar composite tissue exhibited a more heterogeneous width with proximal tendon (0.97 ± 0.034mm) being significantly lower compared to scar tissue (1.65 ± 0.025mm) (p<0.0001) and distal tendon (1.62 ± 0.021mm, p<0.0001) (Figure 2K). Similarly, the thickness of the tendon-scar composite tissue was heterogeneous with proximal tendon (1 ± 0.027mm) being significantly lower compared to scar tissue (1.49 ± 0.014mm, p<0.0001) and distal tendon (1.47 ± 0.008mm, p<0.0001) (Figure 2L).
Scar tissue has significantly different CSA and linear tangent moduli compared to tendon-scar composite tissue at both the proliferative and early remodeling phases
At D14 post-surgery, the scar tissue CSA was approximately 35% larger (p<0.01) compared to the tendon-scar composite tissue due to the heterogeneity in dimensions of the different regions in the tendon- scar composite tissue compared to the more homogeneous scar tissue (Figure 3A). The D14 post-surgery scar tissue CSA was 18.2-fold (p<0.0001) higher compared to CSA of uninjured FDL tendons (Figure S1A), while the CSA of the tendon-scar composite was 11.48-fold (p<0.0001) higher compared to that of uninjured FDL tendons (Figure S1A). The peak load and stiffness between the scar and the tendon-scar composite tissues showed no significant differences (p>0.05) (Figures 3B &C). At D14 post-surgery, the scar and composite tissues exhibited an 88.99% (p<0.0001) and a 91.2% (p<0.0001) significant decrease in peak load compared to healthy FDL tendons, respectively (Figure S1B). In terms of stiffness, the scar and composite tissues exhibited a 90.03% (p<0.0001) and an 87.40% (p<0.0001) significant decrease compared to healthy FDL tendons (Figure S1C). The peak stress values between the scar and the tendon-scar composite tissues did not show any significant differences (p>0.05) (Figure 3D), while the tangent modulus of the scar tissue was almost 6-fold less than that of the tendon-scar composite tissue (p<0.01) (Figure 3E). Scar and composite tissues at D14 post-surgery showed a 99.43% (p<0.0001) and a 99.29% (p<0.0001) significant decrease in peak stress compared to the uninjured FDL tendons, respectively (Figure S1D). As for the tangent modulus, scar and composited D14 tissues exhibited a 99.62% (p<0.0001) and a 97.77% (p<0.0001) significant decrease compared to healthy FDL tendons, respectively (Figure S1E).
Similarly, during the early remodeling phase (D21 post-surgery), the scar tissue CSA was 17.77% larger (p<0.00001) compared to the tendon-scar composite tissue (Figure 3F). The D21 post-surgery scar tissue CSA was 14-fold (p<0.0001) higher compared to CSA of uninjured FDL tendons (Figure S1A), while the CSA of the tendon-scar composite was 11.33-fold (p<0.0001) higher compared to that of uninjured FDL tendons (Figure S1A). Both the peak load stiffness between the scar and the tendon-scar composite tissues did not show any significant differences (p>0.05) (Figure 3G &H). At D21 post-surgery, the scar and composite tissues exhibited an 90.03% (p<0.0001) and a 90.99% (p<0.0001) significant decrease in peak load compared to healthy FDL tendons, respectively (Figure S1B). In terms of stiffness, the scar and composite tissues exhibited a 90.52% (p<0.0001) and an 89.8% (p<0.0001) significant decrease compared to healthy FDL tendons (Figure S1C). The peak stress between the scar and the tendon-scar composite tissues did not show any significant differences (p>0.05) (Figure 3I), while the tangent modulus of the scar tissue was almost 2.6-fold less than that of the tendon-scar composite tissue (p<0.01) (Figure 3J). Scar and composite tissues at D21 post-surgery showed a 99.12% (p<0.0001) and a 99.27% (p<0.0001) significant decrease in peak stress compared to the uninjured FDL tendons, respectively (Figure S1D). As for the tangent modulus, scar and composited D21 tissues exhibited a 99.14% (p<0.0001) and a 97.79% (p<0.0001) significant decrease compared to healthy FDL tendons, respectively (Figure S1E).
Validation of experimentally calculated scar tissue linear tangent moduli values via FEBio
At D14 post-surgery, the tangent modulus of the scar tissue calculated experimentally was slightly lower than the tangent modulus calculated using iFEA. However, this difference was not statistically significant (SEM of differences = 0.15; p=0.2046) (Figure 4D). In a similar manner, at during the early remodeling healing phase (D21 post-surgery), FEA-based tangent modulus values were slightly higher than the experimentally calculated tangent modulus values. However, this difference was also not statistically significant (SEM of differences = 0.07; p=0.3383) (Figure 4E) and was less pronounced than in the D14 group. To further validate our findings, we also simulated an FEBio-based tensile testing where “optical markers” were introduced and the tangent modulus was calculated by considering the strain of optical markers (Figure S3A–F), instead of the whole tissue’s gauge length and compared that with both our experimental data and our initial FEBio simulations at D14 (Figure S3G) and D21 (Figure S3H) post-surgery. At D14 post-surgery, there were no significant differences between the FEBio optical strain and FEBio gauge length (SEM of differences = 0.02; p=0.99), as well as between the FEBio optical strain and the experimental values (SEM of differences = 0.33; p=0.4) (Figure S2G). At D21 post-surgery, there were no differences between the FEBio optical strain and FEBio gauge length (SEM of differences = 0.16; p=0.82), as well as between the FEBio optical strain and the experimental values (SEM of differences = 0.26; p=0.234) (Figure S3H).
Discussion
In this study, our objective was to describe a method allowing for the determination of the true material properties of the scar tissue at different early healing timepoints in a sensitive and robust way Next, we utilized a finite elements approach using the FEBio program to simulate the uniaxial tensile stretching of scar tissues and validated the results we generated experimentally in terms of tissue material quality. We were able to show the importance of dissecting the intrinsic material properties of only the scar tissue and to underscore that with such a method, it will be possible to ‘screen’ different treatment regimens (e.g. cellular ablation, biomechanical and/or biochemical stimuli, tissue engineered scaffolds) and assess whether a specific treatment results in a more regenerative or fibrotic response of the healing tendon by directly quantifying the material properties of the scar tissue. Such mechanical characterization is important because it gives us insight on the direct effect of a treatment regimen on the scar tissue biomechanics. In contrast, mechanical characterization of the material quality in composite tendon-scar tissues will result in an inaccurate understanding of the mechanical environment of the scar tissue since it is the mechanically weakest part of the tendon38,39 and when combined with native non-injured tissue, the sensitivity for detecting any material properties changes in the scar is drastically minimized. We found that the scar tissue exhibits a significant increase in CSA and a significant decrease in tangent modulus compared to the tendon-scar composite at both 14- and 21- days post-surgery. To our knowledge, this is the first study to successfully quantify the mechanical properties of tendon scar tissue and to demonstrate significant differences between scar and tendon-scar composite tissue material properties. These findings highlight the importance of choosing a representative tendon gauge length for material quality assessment during healing. Characterization of the material properties of only the scar tissue, whenever possible, is a direct assessment of the function and material quality of the healing region and might be a better indicator of a more regenerative vs fibrotic healing response of the tendon.
At D14 post-surgery (proliferative healing phase), we found that the CSA of the scar tissue group was significantly higher compared to the tendon-scar composite group and similarly the histological evaluation verified such an increase in the scar CSA. At this phase, various intrinsic and extrinsic cell populations are recruited in the healing region and initiate the production of a provisional scar tissue, mainly collagen III and different proteoglycans to close the wound area and provide an initial partial restoration of the tendon mechanical integrity4,27,46. Consistent with our histological and quantitative characterization of the scar CSA, the provisional scar tissue is characterized by a significant increase in the CSA and a random deposition and orientation of the different secreted ECM molecules in contrast to the highly organized morphology of the collagen fibers and ECM molecules in the healthy tendon tissue4,27,46. Consistent with this, Zhao et al., performed total transection and repair of the flexor digitorum profundus (FDP) tendons in a canine model and they showed that the FDP tendons had a significant increase in the cross-section of the healing region11,17,33,47. We also found that at the same time there were no significant differences in both the peak load and stiffness between the two groups. These data indicate the “attempt” of the injured tendon to bear higher amounts of load. This attempt, although it offers a subsequent amount of strength, it has a counter-effect on the function/material quality of the tissue48–51 as we demonstrated here by the significant differences of the scar tissue versus the tendon-scar composite tissue tangent moduli at both 14- and 21-days post-surgery.
During the early remodeling phase (D21 post-surgery), we found that the CSA of the scar tissue group was significantly higher compared to the tendon-scar composite group. However, the difference of the CSA between the scar and tendon-scar composite tissue at D21 (early remodeling phase) post-surgery was smaller compared to that at D14 (proliferative phase) post-surgery. Also, the scar tissue CSA at D21 post-surgery was smaller than that at D14 post-surgery. These results were further validated by our histological characterization which showed that as we move into the earlier remodeling healing phase, the CSA of the scar seems to decrease. Using the same FDL tendon injury and repair model, we have previously shown that by D21 post-surgery, consistent with our histological findings in this study, the scar tissue was observed to extend throughout the original tendon tissue and to have elevated mRNA expression levels of MMP2 and MMP14, indicating that at this timepoint, the healing tendons are in the early remodeling phase52. As healing moves into the earlier remodeling phase (D21) or consolidation phase, there is a significant decrease in both the cellularity as well as the production of ECM4,46. MMPs are released to help replace Collagen III in the healing region by the much more organized Collagen I, resulting in a slight decrease of the cross-section and in the production of a more fibrous scar tissue46,51. Indeed, using the same FDL tendon injury and repair model, we have previously shown that by D21 post-surgery, Col3a1 mRNA expression levels from both RT-PCR and in-situ hybridization were significantly decrease52. In terms of material quality, the scar tissue tangent modulus was significantly lower compared to that of the tendon-scar composite tissue tangent modulus, however, the difference of the tangent modulus between the two groups at D21 post-surgery was smaller compared to that at D14 post-surgery. These data and our histological characterization indicate that as the scar tissue remodeling continues, the newly produced collagen I fibers start to organize better compared to the collagen III across the longitudinal axis of the tendon tissue, resulting in improvements of the function and material quality of the healing tendon4,46. Indeed, we have previously shown that by D28 post-surgery, there is further decrease of tendon width and an increase in the organization of collagen fibers marked by their parallel orientation to the long tendon axis52. Finally, by D35 post-surgery, healing FDL tendons continue the tissue restoration as evident by the organization of collagen fibers in dense parallel arrangement and the marked decrease of cellular density in the scar tissue area52.
In the healing FDL scar tissue, the aspect ratio (gauge length divided by width) was approximately 1:1 for D14 and ~1.7:1 for D21 post-surgery. Such small aspect ratios could potentially introduce complex stress and strain distributions that impair the accuracy of the uniform stress/strain assumption. To test whether such artifacts were introduced in our mechanically tested scars, we used finite element analysis to simulate our mechanical tests with boundary conditions reflecting the effects of gripping and accurate specimen geometries. This allowed us to use iterative optimization to quantify the “real” tangent modulus (material quality) of the scar independently of artifacts resulting from inaccurate assumptions. By comparing the experimentally calculated versus iFEA-based tangent moduli for scar tissue at D14 and D21, we found no significant differences at all timepoints. Thus, our experimentally calculated moduli reflected the “true” material quality of the scar tissue within the variability of the tested specimens. To further validate our findings, we performed FEA to simulate the current “gold standard” optical strain method and compared our findings with tangent modulus values derived from this method. We found that calculating strain based on tracking marked locations within the tissue did not yielded statistically distinct values of tangent modulus compared with our approach (Supplemental Figure 3). Our approach may be of interest to labs with only basic mechanical testing equipment, as optical tracking requires 1) access to imaging systems that interface with mechanical testing devices; and 2) expertise in accurate tracking of fiducial markers placed on the tissue. Furthermore, because our method does not rely solely on tracking deformation on the surface of the specimen, it may not be sensitive to artifacts resulting from damage to the surface during dissection. Previous studies have also used FE modeling to validate experimental measurements in tested tissues with small aspect ratios. For example, FE analysis was used to investigate the effects of specimen dimensions on strain uniformity for aligned, fibrous soft tissue subjected to simple shear testing53. As in our work, the authors found reasonable agreement between theory and simulation for all geometries considered. However, that study used a more sophisticated transverse isotropic model to account for the aligned structure of mature fibrous tissues and considered a different loading condition (simple shear deformation). In contrast, we used a uniaxial loading configuration and applied a simple constitutive model due to our focus on the isotropic scar tissue that forms in the early stages of tendon healing. Of course, gripping-induced spatial variations in stress and strain were certainly present in our experiments and are evident in our simulations (Supplemental Figure 3). However, the magnitude of their effect on the calculated material properties was not substantial compared with the inherent variability of the acquired data (most likely due to biological variations). Interestingly, when we compared tangent moduli calculated experimentally with tangent moduli calculated using IFEA for D14 scar tissue, although significant changes were not observed, the average modulus appeared higher in the iFEA group. However, the relative difference in tangent modulus between experimental and iFEA-based values of the tangent modulus in the D21 group was smaller, likely because the aspect ratio was higher in this group and stress was therefore more uniform.
This study was not without limitations. First, we did not detect differences in scar tissue material properties between D14 and D21, even when isolating the scar. It is not clear if isolated scar tissue material properties are a more sensitive measure of healing than measures derived from tests performed without isolating the scar or whether after the scar tissue is formed, its material properties do not change until the early remodeling phase (after D21 post-surgery). The model used in our iFE analysis assumed that the tested scar tissue was isotropic and did not account for fiber alignment, collagen uncrimping or collagen realignment. However, we restricted our analysis to the linear region (after collagen uncrimping and realignment have taken place) and only tested scar tissue, which is poorly aligned. In addition, our strain measurements used grip-grip strain instead of optical strain. However, we imaged all specimens on a reflected light microscope before and after testing and did not observe any signs of slippage. Moreover, we simulated our mechanical tests using iFEA with accurate specimen geometries and boundary conditions to confirm the assumptions of our experimental calculations. We also performed FEA to simulate optical strain measurement in our models and found that calculating strain based on tracking marked locations within the tissue would not have yielded statistically distinct values of tangent modulus compared with our approach (Supplemental Figure 3). A further limitation is that we did not look at timepoints beyond D21 of healing, however, the objectives of this study were to show that we can successfully isolate, grip, tensile test, and detect differences in the material quality of only the scar tissue during the different healing phases. We have previously shown that the healing FDL tendons exhibit different healing characteristics between D14- and D21 post-surgery20,21,44, indicative of the different healing phases. Time-points prior to D14 were not analyzed due to sample fragility, low mechanical properties, and insufficient scar formation. In addition, we have not examined the effects of age or sex on the isolated mechanical properties of scar tissue. Considering the clamping only in the scar (small gauge length), another limitation is application of this method to samples during the late-remodeling healing phase, when a significant amount of dense collagen fibers organized in parallel has been produced, due to potential alterations of collagen fiber kinematics. Finally, we believe that it might be technically challenging to apply this method to tendons that are short (patellar tendon) or that have a more complicated geometry (supraspinatus tendons) due to the difficulty of isolating and gripping only the scar tissue.
Collectively, this study, first, demonstrates that the material quality between scar and composite tendon-scar tissues is different between different timepoints of tendon healing. Second, it underscores the importance of carefully choosing the appropriate gauge length for mechanical characterization of healing tissues depending on whether the isolated scar or a composite of scar-native tissue is more appropriate for a given research study. Third, it provides a new method for mechanical characterization of small healing tissues that is highly sensitive in detecting material quality differences at multiple timepoints of tendon healing. This method was successfully validated by comparison with iFEA based on models with accurate specimen geometry and grip-simulating boundary conditions. The approach highlighted in this study will open new technical avenues in the tendon field by making it possible to more directly assess the efficacy of numerous treatment regimens (e.g., cellular ablation, biomechanical and/or biochemical stimuli, tissue engineered scaffolds) on tendon function and material quality.
Supplementary Material
Acknowledgements:
This work was supported in part by NIH/ NIAMS R01AR073169 and R21 AR073961 (to AEL), and R01 AR070765 (to MRB). The HBMI and BBMTI Cores were supported by NIH/ NIAMS P30AR069655. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Footnotes
All authors declare no competing interests in this manuscript
References
- 1.McCormick A, Charlton J & Fleming D Assessing health needs in primary care. Morbidity study from general practice provides another source of information. Bmj 310, 1534, doi: 10.1136/bmj.310.6993.1534d (1995). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Korcari A, Nichols AE, O’Neil M & Loiselle AE Ligament and tendon tissue engineering. Musculoskeletal Tissue Engineering, 81 (2021). [Google Scholar]
- 3.Pennisi E Tending tender tendons. Science 295, 1011, doi: 10.1126/science.295.5557.1011 (2002). [DOI] [PubMed] [Google Scholar]
- 4.Nichols AEC, Best KT & Loiselle AE The cellular basis of fibrotic tendon healing: challenges and opportunities. Transl Res 209, 156–168, doi: 10.1016/j.trsl.2019.02.002 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Tempfer H & Traweger A Tendon Vasculature in Health and Disease. Front Physiol 6, 330, doi: 10.3389/fphys.2015.00330 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Thomopoulos S, Parks WC, Rifkin DB & Derwin KA Mechanisms of tendon injury and repair. J Orthop Res 33, 832–839, doi: 10.1002/jor.22806 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Korcari A, Nichols AEC & Loiselle AE Depletion of Scleraxis-lineage cells accelerates tendon ECM aging and retains remodeling tenocytes that enhance tendon healing. BioArxiv, doi: 10.1101/2022.01.20.477119 (2022). [DOI] [Google Scholar]
- 8.Burks RT, Haut RC & Lancaster RL Biomechanical and histological observations of the dog patellar tendon after removal of its central one-third. Am J Sports Med 18, 146–153, doi: 10.1177/036354659001800207 (1990). [DOI] [PubMed] [Google Scholar]
- 9.Loiselle AE et al. Development of antisense oligonucleotide (ASO) technology against Tgf-beta signaling to prevent scarring during flexor tendon repair. J Orthop Res 33, 859–866, doi: 10.1002/jor.22890 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Cui H et al. Macrophage-Derived miRNA-Containing Exosomes Induce Peritendinous Fibrosis after Tendon Injury through the miR-21–5p/Smad7 Pathway. Mol Ther Nucleic Acids 14, 114–130, doi: 10.1016/j.omtn.2018.11.006 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Zhao C et al. Resurfacing with chemically modified hyaluronic acid and lubricin for flexor tendon reconstruction. J Orthop Res 31, 969–975, doi: 10.1002/jor.22305 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Johnston JM et al. Collagen V haploinsufficiency in a murine model of classic Ehlers-Danlos syndrome is associated with deficient structural and mechanical healing in tendons. J Orthop Res 35, 2707–2715, doi: 10.1002/jor.23571 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Izu Y et al. Dysfunctional tendon collagen fibrillogenesis in collagen VI null mice. Matrix Biol 30, 53–61, doi: 10.1016/j.matbio.2010.10.001 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Connizzo BK, Han L, Birk DE & Soslowsky LJ Collagen V-heterozygous and -null supraspinatus tendons exhibit altered dynamic mechanical behaviour at multiple hierarchical scales. Interface Focus 6, 20150043, doi: 10.1098/rsfs.2015.0043 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Robinson KA et al. Decorin and biglycan are necessary for maintaining collagen fibril structure, fiber realignment, and mechanical properties of mature tendons. Matrix Biol 64, 81–93, doi: 10.1016/j.matbio.2017.08.004 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Neidlin M, Korcari A, Macheras G & Alexopoulos LG Cue-signal-response analysis in 3d chondrocyte scaffolds with anabolic stimuli. Annals of biomedical engineering 46, 345–353 (2018). [DOI] [PubMed] [Google Scholar]
- 17.Zhao C et al. Effects of lubricant and autologous bone marrow stromal cell augmentation on immobilized flexor tendon repairs. J Orthop Res 34, 154–160, doi: 10.1002/jor.22980 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Abraham AC et al. Targeting the NF-kappaB signaling pathway in chronic tendon disease. Sci Transl Med 11, doi: 10.1126/scitranslmed.aav4319 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Best KT, Lee FK, Knapp E, Awad HA & Loiselle AE Deletion of NFKB1 enhances canonical NF-kappaB signaling and increases macrophage and myofibroblast content during tendon healing. Sci Rep 9, 10926, doi: 10.1038/s41598-019-47461-5 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Best KT & Loiselle AE Scleraxis lineage cells contribute to organized bridging tissue during tendon healing and identify a subpopulation of resident tendon cells. Faseb j 33, 8578–8587, doi: 10.1096/fj.201900130RR (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Best KT et al. Scleraxis-Lineage Cell Depletion Improves Tendon Healing and Disrupts Adult Tendon Homeostasis. doi: 10.1101/2020.02.01.930255 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Kaji DA, Howell KL, Balic Z, Hubmacher D & Huang AH Tgfbeta signaling is required for tenocyte recruitment and functional neonatal tendon regeneration. Elife 9, doi: 10.7554/eLife.51779 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Wang Y et al. Aspirin inhibits inflammation and scar formation in the injury tendon healing through regulating JNK/STAT-3 signalling pathway. Cell Prolif 52, e12650, doi: 10.1111/cpr.12650 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Lin D et al. Tenomodulin is essential for prevention of adipocyte accumulation and fibrovascular scar formation during early tendon healing. Cell Death Dis 8, e3116, doi: 10.1038/cddis.2017.510 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Norelli JB et al. Tenogenically differentiated adipose-derived stem cells are effective in Achilles tendon repair in vivo. J Tissue Eng 9, 2041731418811183, doi: 10.1177/2041731418811183 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Komura S et al. Induced pluripotent stem cell-derived tenocyte-like cells promote the regeneration of injured tendons in mice. Sci Rep 10, 3992, doi: 10.1038/s41598-020-61063-6 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Sakabe T et al. Transcription factor scleraxis vitally contributes to progenitor lineage direction in wound healing of adult tendon in mice. J Biol Chem 293, 5766–5780, doi: 10.1074/jbc.RA118.001987 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Chamberlain CS et al. Extracellular Vesicle-Educated Macrophages Promote Early Achilles Tendon Healing. Stem Cells 37, 652–662, doi: 10.1002/stem.2988 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Ackerman JE et al. Cell non-autonomous functions of S100a4 drive fibrotic tendon healing. Elife 8, doi: 10.7554/eLife.45342 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Majewski M et al. Improved tendon healing using bFGF, BMP-12 and TGFbeta1 in a rat model. Eur Cell Mater 35, 318–334, doi: 10.22203/eCM.v035a22 (2018). [DOI] [PubMed] [Google Scholar]
- 31.Muller SA, Evans CH, Heisterbach PE & Majewski M The Role of the Paratenon in Achilles Tendon Healing: A Study in Rats. Am J Sports Med 46, 1214–1219, doi: 10.1177/0363546518756093 (2018). [DOI] [PubMed] [Google Scholar]
- 32.Freeberg MAT et al. Serpine1 Knockdown Enhances MMP Activity after Flexor Tendon Injury in Mice: Implications for Adhesions Therapy. Sci Rep 8, 5810, doi: 10.1038/s41598-018-24144-1 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Zhao C et al. CORR(R) ORS Richard A. Brand Award for Outstanding Orthopaedic Research: Engineering flexor tendon repair with lubricant, cells, and cytokines in a canine model. Clin Orthop Relat Res 472, 2569–2578, doi: 10.1007/s11999-014-3690-y (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Vanhees M et al. The effect of suture preloading on the force to failure and gap formation after flexor tendon repair. J Hand Surg Am 38, 56–61, doi: 10.1016/j.jhsa.2012.09.030 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.George NS, Bell R, Paredes JJ, Taub PJ & Andarawis-Puri N Superior mechanical recovery in male and female MRL/MpJ tendons is associated with a unique genetic profile. J Orthop Res, doi: 10.1002/jor.24705 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Paredes J, Marvin JC, Vaughn B & Andarawis-Puri N Innate tissue properties drive improved tendon healing in MRL/MpJ and harness cues that enhance behavior of canonical healing cells. FASEB J 34, 8341–8356, doi: 10.1096/fj.201902825RR (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Paredes J, Pekmezian A & Andarawis-Puri N MRL/MpJ tendon matrix-derived therapeutic promotes improved healing outcomes in scar-mediated canonical tendon healing. J Orthop Res, doi: 10.1002/jor.24754 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Freedman BR et al. Tendon healing affects the multiscale mechanical, structural and compositional response of tendon to quasi-static tensile loading. J R Soc Interface 15, doi: 10.1098/rsif.2017.0880 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Freedman BR et al. Dynamic Loading and Tendon Healing Affect Multiscale Tendon Properties and ECM Stress Transmission. Sci Rep 8, 10854, doi: 10.1038/s41598-018-29060-y (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Ackerman JE & Loiselle AE Murine Flexor Tendon Injury and Repair Surgery. J Vis Exp, doi: 10.3791/54433 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Kinugasa R et al. A Multi-modality Approach Towards Elucidation of the Mechanism for Human Achilles Tendon Bending During Passive Ankle Rotation. Sci Rep 8, 4319, doi: 10.1038/s41598-018-22661-7 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Oshima T, Nakase J, Numata H, Takata Y & Tsuchiya H The cross-sectional shape of the fourfold semitendinosus tendon is oval, not round. J Exp Orthop 3, 28, doi: 10.1186/s40634-016-0063-3 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Navarro J et al. Method development and characterization of chick embryo tendon mechanical properties. Journal of Biomechanics 133, 110970, doi: 10.1016/j.jbiomech.2022.110970 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Best KT et al. NF-kappaB activation persists into the remodeling phase of tendon healing and promotes myofibroblast survival. Sci Signal 13, doi: 10.1126/scisignal.abb7209 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Ackerman JE et al. Cell non-autonomous functions of S100a4 drive fibrotic tendon healing. Elife 8, doi:ARTN e45342 10.7554/eLife.45342 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Docheva D, Muller SA, Majewski M & Evans CH Biologics for tendon repair. Adv Drug Deliv Rev 84, 222–239, doi: 10.1016/j.addr.2014.11.015 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Zhao C et al. The effects of biological lubricating molecules on flexor tendon reconstruction in a canine allograft model in vivo. Plast Reconstr Surg 133, 628e–637e, doi: 10.1097/PRS.0000000000000102 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Kew SJ et al. Regeneration and repair of tendon and ligament tissue using collagen fibre biomaterials. Acta Biomater 7, 3237–3247, doi: 10.1016/j.actbio.2011.06.002 (2011). [DOI] [PubMed] [Google Scholar]
- 49.Longo UG, Lamberti A, Maffulli N & Denaro V Tendon augmentation grafts: a systematic review. Br Med Bull 94, 165–188, doi: 10.1093/bmb/ldp051 (2010). [DOI] [PubMed] [Google Scholar]
- 50.Ricchetti ET, Aurora A, Iannotti JP & Derwin KA Scaffold devices for rotator cuff repair. J Shoulder Elbow Surg 21, 251–265, doi: 10.1016/j.jse.2011.10.003 (2012). [DOI] [PubMed] [Google Scholar]
- 51.Snedeker JG & Foolen J Tendon injury and repair - A perspective on the basic mechanisms of tendon disease and future clinical therapy. Acta Biomater 63, 18–36, doi: 10.1016/j.actbio.2017.08.032 (2017). [DOI] [PubMed] [Google Scholar]
- 52.Loiselle AE et al. Remodeling of murine intrasynovial tendon adhesions following injury: MMP and neotendon gene expression. J Orthop Res 27, 833–840, doi: 10.1002/jor.20769 (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Gardiner JC & Weiss JA Simple shear testing of parallel-fibered planar soft tissues. J Biomech Eng 123, 170–175, doi: 10.1115/1.1351891 (2001). [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.